| Patent Number |
Title Of Patent |
Date Issued |
| 6953579 |
Chimeric virus-like particle or chimeric capsomers from BPV |
October 11, 2005 |
| The present invention relates to chimeric virus-like particles (cVLPs) or chimeric capsomers (cCs) from BPV, fusion proteins and DNAs coding for said proteins and to the use of cVLPs or cCs for the immunization of ungulates, especially horses. |
| 6723317 |
Antibodies specific for seroreactive regions on HPV 16 protein E1 |
April 20, 2004 |
| The invention relates to seroreactive regions on proteins E1 and E2 of human papillomavirus (HPV) 16. The application also relates to a vaccine which contains such peptides which contain the seroreactive regions. The invention likewise embraces compositions for diagnostic purposes which |
| 6531127 |
Antibodies that specifically react with seroreactive regions on HPV 16 proteins E1 and E2 |
March 11, 2003 |
| The invention relates to seroreactive regions on the E1 and E2 proteins of human papillomavirus 16 (HPV 16). The invention also relates to a vaccine that contains peptides comprising at least one seroreactive region of the E1 and/or E2 proteins. The invention likewise embraces compositio |
| 6322794 |
Seroreactive epitopes on proteins of human papillomavirus (HPV) 18 |
November 27, 2001 |
| The invention relates to seroreactive epitopes on proteins of human papillomavirus HPV18.In addition, the invention relates to peptides which have amino-acid sequences which coincide in whole or in part with the sequences of the seroreactive epitopes, and to vaccines which contain such p |
| 6221577 |
Seroreactive regions on HPV 16-proteins E1 and E2 |
April 24, 2001 |
| The invention relates to seroreactive regions on protein E1 and E2 of human papillomavirus (HPV) 16. The application also relates to a vaccine which contains such peptides which contain the seroreactive regions. The invention likewise embraces compositions for diagnostic purposes which |
| 5753233 |
Seroreactive epitopes on proteins of human papilloma-virus (HPV) 18 |
May 19, 1998 |
| The invention relates to seroreactive epitopes on proteins of human papillomavirus HPV18.In addition, the invention relates to peptides which have amino-acid sequences which coincide in whole or in part with the sequences of the seroreactive epitopes, and to vaccines which contain such p |
| 5629161 |
Use of HVP-16 E6 and E7-gene derived peptides to diagnose HPV-16-associated invasive cervical ca |
May 13, 1997 |
| The present invention relates to the use of human paillomavirus 16 (HPV-16) E7-gene derived peptides for the diagnostic identification of HPV-16-associated invasive cervical cancer. |
| 5601973 |
Seroreactive regions on HPV 16 proteins E1 and E2 |
February 11, 1997 |
| The invention relates to seroreactive regions on proteins E1 and E2 of human papillomavirus (HPV) 16.The application also relates to a vaccine which contains such peptides which contain the seroreactive regions.The invention likewise embraces compositions for diagnostic purposes which co |
| 5547846 |
Immunogenic regions on the E7 protein of human papillomavirus type 16 |
August 20, 1996 |
| The invention describes two immunogenic regions of the E7 protein of human papillomavirus type 16 (HPV 16), one immunoreactive region being located downstream from nucleotide 595 and the other being located downstream from nucleotide 667 of the HPV 16 genome. |
